CA3171263A1 — Compositions and methods for naloxone delivery
Assigned to Purdue Pharma LP · Expires 2021-09-16 · 5y expired
What this patent protects
Disclosed in certain embodiments is a formulation comprising a therapeutically effective amount of naloxone or a pharmaceutically acceptable salt thereof and an adjuvant that enhances the absorption of the naloxone into the systemic circulation of a subject. Also disclosed herein…
USPTO Abstract
Disclosed in certain embodiments is a formulation comprising a therapeutically effective amount of naloxone or a pharmaceutically acceptable salt thereof and an adjuvant that enhances the absorption of the naloxone into the systemic circulation of a subject. Also disclosed herein are a method of treatment and a kit that may be utilized in treatment.
Drugs covered by this patent
- naloxone-hydrochloride (Naloxone Hydrochloride) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.